Chronic granulomatous large-vessel vasculitis targeting the aorta and its primary branches, producing progressive stenosis, occlusion, and aneurysm formation — classified under ICD-10-CM as Takayasu arteritis (aortic arch syndrome).

Documentation tips

What should appear in the chart to support M31.4.

Source · Editorial brief grounded in 5 cited references ↓

• Document the confirmed diagnosis as 'Takayasu arteritis' or 'aortic arch syndrome (Takayasu)' — not generic 'vasculitis' or 'arteritis,' which won't support M31.4 specificity.
• Record imaging findings explicitly: which arterial segments show stenosis, occlusion, or aneurysm (e.g., left subclavian 70% stenosis on CTA), and whether findings are new or progressive.
• Note asymmetric or absent upper-extremity pulses and any blood pressure differential between arms, as these are key clinical validators for large-vessel Takayasu involvement.
• Capture laboratory markers supporting active inflammation — ESR, CRP, IL-6 — along with any biopsy or PET/CT findings confirming active arterial wall inflammation.
• If renovascular hypertension, cerebral ischemia, or retinopathy is present as a consequence, code those complications separately in addition to M31.4 — do not bury them in the M31.4 encounter description.

Related CPT procedures

Procedure codes commonly billed with M31.4. Linking the right diagnosis to the right procedure is what establishes medical necessity.

Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis

Common coding pitfalls

The recurring mistakes coders make with M31.4 and adjacent codes.

Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓

• Using M31.6 (Other giant cell arteritis) or M31.5 (Giant cell arteritis with PMR) for Takayasu arteritis — those codes explicitly exclude M31.4; Takayasu affects large vessels in younger patients, not the cranial/temporal arteries of giant cell arteritis.
• Coding M31.9 (Necrotizing vasculopathy, unspecified) when the record clearly documents Takayasu's disease — M31.4 is billable and specific; M31.9 will flag as under-coded on audit.
• Omitting secondary codes for documented complications (renovascular hypertension I15.0, upper-extremity claudication, cerebrovascular ischemia) that affect DRG weight and justify higher-resource encounters.
• Confusing Takayasu arteritis with aortic aneurysm codes (I71.x) — when aneurysm is a sequela of Takayasu, code M31.4 as the underlying cause and the aneurysm code as a secondary complication.

Clinical context

Source · Editorial summary grounded in 5 cited references ↓

Sibling codes

Other billable codes under M31 (laterality / anatomic variants).